While early reports indicated that some PAH patients with TBX4 variants showed a milder presentation, it has recently been recognized that the clinical phenotypes associated with TBX4 disruption represent a broad spectrum, ranging from transient neonatal PH to severe progressive or biphasic PH, with or without developmental disorders [77]. Here, TBX4 is linked to pulmonary arterial hypertension.